Actively Recruiting
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Led by Shengjing Hospital · Updated on 2025-05-15
50
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to investigate the value of MR elastography-based SII as a means of detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct measure of tumor-liver adhesion to investigate the relationship between imaging findings and pathophysiological changes in the Liver.
CONDITIONS
Official Title
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed colorectal liver metastases
- Pathologic results available from surgical patients
- No contraindications for MRI examination
You will not qualify if you...
- Poor image quality not meeting measurement standards
- Colorectal liver metastases smaller than 1 cm in diameter
- Presence of dysfunction in other important organs
- Presence of other malignant tumors
- Patients who do not provide informed consent
- Presence of metallic implants or foreign bodies such as pacemakers, artificial metallic heart valves, metal joints, metal implants, non-removable dentures, insulin pumps, or contraceptive rings
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China, 110004
Actively Recruiting
Research Team
Y
Yu Shi, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here